Abstract
Background: The identification of factors associated with Intensive Care Unit (ICU) mortality and derived clinical phenotypes in COVID-19 patients could help for a more tailored approach to clinical decision-making that improves prognostic outcomes. The objective was to analyze patient’s factors associated with mortality risk and utilize a Machine Learning(ML) to derive clinical COVID-19 phenotypes.Methods: Prospective, multicenter, observational study of critically ill patients with confirmed COVID-19 disease and acute respiratory failure admitted from 63 Intensive Care Units(ICU) in Spain. Patient features including demographics and clinical data at ICU admission were analyzed. Generalized linear models were used to determine ICU morality risk factors. An unsupervised clustering analysis was applied to determine presence of phenotypes. The prognostic models were validated and their performance was measured using accuracy test, sensitivity, specificity and ROC curves.Findings: The database included a total of 2,022 patients (mean age 64[IQR5-71] years, 1423(70·4%) male, median APACHE II score (13[IQR10-17]) and SOFA score (5[IQR3-7]) points. The ICU mortality rate was 32·6%. Of the 3 derived phenotypes, the C(severe) phenotype was the most common (857;42·5%) and was characterized by the interplay of older age (>65 years), high severity of illness and a higher likelihood of development shock. The A(mild) phenotype (537;26·7%) included older age (>65 years), fewer abnormal laboratory values and less development of complications and B (moderate) phenotype (623,30·8%) had similar characteristics of A phenotype but were more likely to present shock. Crude ICU mortality was 45·4%, 25·0% and 20·3% for the C, B and A phenotype respectively. The ICU mortality risk factors and model performance differed between whole population and phenotype classifications.Interpretation: The presented ML model identified three clinical phenotypes that significantly correlated with host-response patterns and ICU mortality. Different risk factors across the whole population and clinical phenotypes were observed which may limit the application of a “one-size-fits-all” model in practice.Funding Statement: This study was supported by the Spanish Intensive Care Society(SEMICYUC) and Ricardo Barri Casanovas Foundation.Declaration of Interests: All authors declare that they have no conflicts of interest.Ethics Approval Statement: The study was approved by the reference institutional review board at Joan XXIII University Hospital (IRB# CEIM/066/2020) and each participating site with a waiver of informed consent. All data values were anonymized prior to the phenotyping which consisted of clustering clinical variables on their association with COVID-19 mortality.
Highlights
Since the outbreak of COVID-19 disease began in December 2019 in China, soaring cases of confirmed SARS-CoV-2 are pummeling the global health system
The presented ML model identified three clinical phenotypes that significantly correlated with host-response patterns and Intensive Care Unit (ICU) mortality
The severity of illness was high according to the Acute Physiology and Chronic Health Evaluation (APACHE) Acute Physiology and Chronic Health Evaluation II (II) (14; interquartile range (IQR) 11-18) and Sequential Organ Failure Assessment (SOFA) (5.7; IQR 4-7.3) scores
Summary
Since the outbreak of COVID-19 disease began in December 2019 in China, soaring cases of confirmed SARS-CoV-2 are pummeling the global health system. More than 61 million people have developed SARS-CoV-2 infection, and more than 1 million have died[1]. As of November 30, 2020 more 1.6 million people in Spain have been infected with SARS-CoV-2 and more than 40,000 have died[3]. The heterogeneity of patients that have been treated in China[4], Italy[8], USA5-7 or Spain[9,10] may explain the wide variation of mortality rate due to their population characteristics, presence of comorbidities and healthcare systems. The identification of factors associated with Intensive Care Unit (ICU) mortality and derived clinical phenotypes in COVID19 patients could help for a more tailored approach to clinical decision-making that improves prognostic outcomes
Submitted Version (Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have